|
시장보고서
상품코드
2040712
집단건강관리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 제공 형태별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)Population Health Management Market Size, Share & Trends Analysis Report By Product (Software, Services), By Delivery Mode (On-premise, Cloud-based), By End-use (Providers, Payers, Employer Groups), By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
집단건강관리 시장 요약
세계의 집단건강관리 시장 규모는 2025년에 1,036억 달러로 추정되며, 2033년까지 5,141억 달러에 달할 것으로 예측됩니다.
2026년부터 2033년까지 CAGR 22.2%로 성장할 것으로 예상됩니다. 의료 산업은 종이 기반 시스템에서 디지털화로 빠르게 전환하고 있으며, 의료 IT 서비스에 대한 수요가 증가하고 있습니다.
또한, 의료 서비스 제공자를 위한 솔루션에 대한 수요가 증가함에 따라 종량제(FFS)에서 가치 기반 지불(VBP) 모델로의 전환이 진행되고 있습니다. 효과적인 질병 관리 전략에 대한 수요 증가는 시장 성장을 촉진할 것으로 예상됩니다.
집단건강관리(PHM)는 사람들의 건강과 웰빙을 개선하고, 치료 경험을 개선하며, 궁극적으로 의료 비용을 절감하기 위한 체계적이고 혁신적인 데이터 기반 접근 방식으로 괄목할 만한 성장을 거듭하고 있습니다. 사우디아라비아를 포함한 전 세계 많은 국가들이 공중보건 문제에 대응하기 위해 PHM을 도입하고 있습니다.
의료업계에서는 가치에 기반한 보상체계를 실현하기 위해 전자건강기록(EHR), PHM 등 의료 IT 솔루션의 도입이 점점 더 활발해지고 있습니다. 의료 서비스 제공자는 PHM 솔루션을 통해 비용 절감과 진료 모델 개선을 기대할 수 있습니다. PHM 솔루션은 더 나은 임상 결과를 얻기 위해 분석, 보고서 작성 및 EHR 시스템과의 의료 데이터 통합 기능을 제공합니다.
또한, 의료 산업이 양 기반 의료에서 가치 기반 의료로 전환함에 따라 위험 감소, 결과 개선, 적절한 사용을 촉진하는 인센티브에 대한 노력이 강화되고 있습니다. 많은 조직에서 PHM의 도입은 심혈관질환, 당뇨병, 고혈압 등 만성질환 관리에서 시작됩니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 집단건강관리 시장 : 변수, 동향, 범위
제4장 집단건강관리 시장 : 제품별 추정·동향 분석
제5장 집단건강관리 시장 : 제공 형태별 추정·동향 분석
제6장 집단건강관리 시장 : 최종 용도별 추정·동향 분석
제7장 집단건강관리 시장 : 지역별 추정·동향 분석
제8장 집단건강관리 시장 : 경쟁 분석
KSM 26.06.04Population Health Management Market Summary
The global population health management market size was estimated at USD 103.6 billion in 2025 and is projected to reach USD 514.1 billion by 2033, growing at a CAGR of 22.2% from 2026 to 2033. The medical industry is rapidly transitioning from a paper-based system to digitization, increasing demand for healthcare IT services.
In addition, increasing demand for solutions for healthcare providers has led to a shift from Fee-For-Service (FFS) to Value-Based Payment (VBP) models. The rising demand for effective disease management strategies is expected to boost market growth.
Population Health Management (PHM) has reported significant growth as a systematic, revolutionary, and data-driven approach to enhance the health & well-being of the population and improve the care experience, ultimately reducing the cost of care. Several countries have adopted PHM globally to cater to public health issues, including Saudi Arabia.
The healthcare industry is increasingly adopting healthcare IT solutions, such as Electronic Health Records (EHRs) and PHM, for value-based compensation. Healthcare providers are likely to benefit from PHM solutions, resulting in financial savings and improved care models. PHM solutions offer analytics, reporting, and healthcare data integration with EHR systems for better clinical outcomes.
Furthermore, the transition of the healthcare industry to value-based healthcare from volume-based healthcare has strengthened the approach for incentives around risk reduction, improving outcomes, and appropriate utilization. For most organizations, PHM adoption starts with the management of chronic conditions such as cardiovascular diseases, diabetes, and hypertension.
Global Population Health Management Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global population health management market report based on the product, delivery mode, end-use, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Software
- Services
- Delivery Mode Outlook (Revenue, USD Million, 2021 - 2033)
- On-Premise
- Cloud-based
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Providers
- Payers
- Employer Groups
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Norway
- Denmark
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Delivery Mode Segment
- 1.2.3. End Use
- 1.3. Information analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data validation & publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
Chapter 3. Population Health Management Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.2.3. Market opportunity analysis
- 3.2.4. Market challenges analysis
- 3.3. Population Health Management Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.2.4. Environmental Landscape
- 3.3.2.5. Legal Landscape
- 3.3.2.6. Social Landscape
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
Chapter 4. Population Health Management Market: Product Estimates & Trend Analysis
- 4.1. Segment Definition
- 4.2. Product Movement Analysis & Market Share, 2025 & 2033
- 4.3. Population Health Management Market: Product Segment Dashboard
- 4.4. Global Population Health Management Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
- 4.4.1. Software
- 4.4.1.1. Software market estimates and forecast, 2021 - 2033 (USD Million)
- 4.4.2. Services
- 4.4.2.1. Services market estimates and forecast, 2021 - 2033 (USD Million)
- 4.4.1. Software
Chapter 5. Population Health Management Market: Delivery Mode Estimates & Trend Analysis
- 5.1. Segment Definition
- 5.2. Delivery Mode Movement Analysis & Market Share, 2025 & 2033
- 5.3. Population Health Management Market: Delivery Mode Segment Dashboard
- 5.4. Global Population Health Management Market Estimates & Forecasts, by Delivery Mode, 2021 to 2033 (USD Million)
- 5.4.1. On-Premise
- 5.4.1.1. On-Premise estimates and forecast, 2021 - 2033 (USD Million)
- 5.4.2. Cloud-based
- 5.4.2.1. Cloud-based estimates and forecast, 2021 - 2033 (USD Million)
- 5.4.1. On-Premise
Chapter 6. Population Health Management Market: End Use Estimates & Trend Analysis
- 6.1. Segment Definition
- 6.2. End Use Movement Analysis & Market Share, 2025 & 2033
- 6.3. Population Health Management Market: End Use Segment Dashboard
- 6.4. Global Population Health Management Market Estimates & Forecasts by End Use, 2021 to 2033 (USD Million)
- 6.4.1. Healthcare Providers
- 6.4.1.1. Healthcare Providers market estimates and forecast, 2021 - 2033 (USD Million)
- 6.4.2. Payers
- 6.4.2.1. Payers market estimates and forecast, 2021 - 2033 (USD Million)
- 6.4.3. Employer Groups
- 6.4.3.1. Employer groups market estimates and forecast, 2021 - 2033 (USD Million)
- 6.4.1. Healthcare Providers
Chapter 7. Population Health Management Market: Region Estimates & Trend Analysis
- 7.1. Regional Market Dashboard
- 7.2. Regional Market Key Takeaways
- 7.3. Market Size, & Forecasts, Revenue and Trend Analysis, 2025 to 2033
- 7.4. North America
- 7.4.1. North America population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. U.S. population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Canada population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. Mexico population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5. Europe
- 7.5.1. Europe population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. UK population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.3. Germany
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Germany population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. France population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Italy population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.6. Spain
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Spain population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.7. Sweden
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Sweden population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.8. Norway
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Competitive Scenario
- 7.5.8.3. Regulatory Framework
- 7.5.8.4. Norway population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.9. Denmark
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Competitive Scenario
- 7.5.9.3. Regulatory Framework
- 7.5.9.4. Denmark population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Japan population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. China population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. India population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Australia population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.6. Thailand
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Thailand population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.7. South Korea
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. South Korea population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Brazil population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Argentina population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.8. MEA
- 7.8.1. MEA population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. South Africa population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Saudi Arabia population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. UAE population health management market estimates and forecast, 2021 - 2033 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Competitive Scenario
- 7.8.5.3. Regulatory Framework
- 7.8.5.4. Kuwait population health management market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 8. Population Health Management Market - Competitive Analysis
- 8.1. Participant Overview
- 8.2. Financial Performance
- 8.3. Product Benchmarking
- 8.4. Company Categorization
- 8.5. Company Market Position Analysis
- 8.6. Company Profiles
- 8.6.1. Veradigm LLC
- 8.6.1.1. Company overview
- 8.6.1.2. Financial performance
- 8.6.1.3. Product benchmarking
- 8.6.1.4. Strategic Initiatives
- 8.6.2. Oracle
- 8.6.2.1. Company overview
- 8.6.2.2. Financial performance
- 8.6.2.3. Product benchmarking
- 8.6.2.4. Strategic Initiatives
- 8.6.3. Conifer Health Solutions, LLC
- 8.6.3.1. Company overview
- 8.6.3.2. Financial performance
- 8.6.3.3. Product benchmarking
- 8.6.3.4. Strategic Initiatives
- 8.6.4. eClinicalWorks
- 8.6.4.1. Company overview
- 8.6.4.2. Financial performance
- 8.6.4.3. Product benchmarking
- 8.6.4.4. Strategic Initiatives
- 8.6.5. Cedar Gate Technologies
- 8.6.5.1. Company overview
- 8.6.5.2. Financial performance
- 8.6.5.3. Product benchmarking
- 8.6.5.4. Strategic Initiatives
- 8.6.6. McKesson Corporation
- 8.6.6.1. Company overview
- 8.6.6.2. Financial performance
- 8.6.6.3. Product benchmarking
- 8.6.6.4. Strategic Initiatives
- 8.6.7. Medecision
- 8.6.7.1. Company overview
- 8.6.7.2. Financial performance
- 8.6.7.3. Product benchmarking
- 8.6.7.4. Strategic initiatives
- 8.6.8. Optum, Inc.
- 8.6.8.1. Company overview
- 8.6.8.2. Financial performance
- 8.6.8.3. Product benchmarking
- 8.6.8.4. Strategic initiatives
- 8.6.9. Advisory Board
- 8.6.9.1. Company overview
- 8.6.9.2. Financial performance
- 8.6.9.3. Product benchmarking
- 8.6.9.4. Strategic initiatives
- 8.6.10. Koninklijke Philips N.V.
- 8.6.10.1. Company overview
- 8.6.10.2. Financial performance
- 8.6.10.3. Product benchmarking
- 8.6.10.4. Strategic initiatives
- 8.6.11. Athenahealth, Inc.
- 8.6.11.1. Company overview
- 8.6.11.2. Financial performance
- 8.6.11.3. Product benchmarking
- 8.6.11.4. Strategic initiatives
- 8.6.12. Welltok
- 8.6.12.1. Company overview
- 8.6.12.2. Financial performance
- 8.6.12.3. Product benchmarking
- 8.6.12.4. Strategic initiatives
- 8.6.1. Veradigm LLC
